Reduced appropriate implantable cardioverter-defibrillator therapy after cardiac resynchronization therapy-induced

Neal A Chatterjee1, Attila Roka1, Steven A Lubitz1

  • 1Department of Medicine and the Cardiac Arrhythmia Service, GRB 109, Massachusetts General Hospital Heart Center, 55 Fruit Street, Boston, MA 02411, USA.

European Heart Journal
|August 13, 2015
PubMed

Insights

Improved left ventricular ejection fraction (LVEF) after cardiac resynchronization therapy (CRT) significantly reduces appropriate implantable cardioverter-defibrillator (ICD) therapy. Patients with LVEF recovery, especially ≥45%, or primary prevention ICD indication face the lowest risk.

Area of Science:

  • Cardiology
  • Electrophysiology
  • Medical Devices

Background:

  • Cardiac resynchronization therapy (CRT) with an implantable cardioverter-defibrillator (ICD) is a common treatment for heart failure.
  • Assessing the impact of CRT-induced left ventricular ejection fraction (LVEF) improvement on ICD therapy is crucial for patient management.

Purpose of the Study:

  • To evaluate the association between LVEF recovery following CRT and the incidence of appropriate ICD therapy.
  • To identify patient subgroups at lower risk for ICD therapy after CRT.

Main Methods:

  • A meta-analysis was performed on data from 6 retrospective cohort studies, including 1740 patients.
  • Pooled incidence rates of appropriate ICD therapy were compared between patients with and without LVEF recovery post-CRT, using various LVEF thresholds (≥35% and ≥45%).

Main Results:

  • Significant reductions in appropriate ICD therapy were observed in patients with LVEF recovery (≥35% or ≥45%) compared to those without.
  • Patients achieving LVEF ≥45% had an estimated ICD therapy rate of 2.3/100 person-years.
  • Patients with a primary prevention ICD indication had very low rates of ICD therapy (0.4-0.8/100 person-years), irrespective of LVEF recovery.

Conclusions:

  • Recovery of LVEF after CRT is linked to a substantially lower incidence of appropriate ICD therapy.
  • Patients demonstrating significant LVEF improvement (≥45%) or those with a primary prevention ICD indication are associated with the lowest risk of appropriate ICD therapy.
Abstract

Related Concept Videos

Heart Failure VI: Adjunct Therapies01:22

Heart Failure VI: Adjunct Therapies

Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
635
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
798
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
810
Cardiomyopathy IV: Restrictive Cardiomyopathy01:29

Cardiomyopathy IV: Restrictive Cardiomyopathy

Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...
957
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
761